Allergy Therapeutics Share Discussion Threads

[richsawko] 07/3/2019 11:15

Wow some massive sells today!

[maddox] 06/3/2019 21:04

Hi eltorres70,

I see that you registered last Nov, have made no other posts and have no profile info - so what's your story and past involvement with AGY?

Regards Maddox

[eltorres70] 06/3/2019 19:51

Usual irrelevant news...In what way can a production site, formerly known as Inmunal (a company with a widely known bad reputation in Spain, shady practices and low quality pharmaceuticals), be of any help with Brexit? Thought it was outrageous when I heard they acquired in the first place, now they're trying to pass this as Brexit's safe net? Still don't understand how people are still putting up with this charade. Every news they put out makes me feel more grateful I pulled out my investment

[spooky] 06/3/2019 12:31

Jimmy, if it was obvious from the RNSs i wouldn't have asked the question.

[volsung] 06/3/2019 12:25

Bought a few. Looks bottomed out

[jimmyloser] 06/3/2019 12:22

see the RNS's it is all there.

[spooky] 06/3/2019 12:10

Does anyone have any idea who the seller is?

[spooky] 06/3/2019 10:41

I think the jam is already there but the current seller is preventing people from seeing it.

[jimmyloser] 06/3/2019 09:44

LOL,
I shouldn't think so until that jam, becomes to-days jam, and not tomorrow's!
The shares should pick up before month end if my hunch is correct.
dyor etc

[spooky] 06/3/2019 09:31

I really like the business but the shares appear to be on a fast road to nowhere. Any chance they could get taken out?

[jimmyloser] 06/3/2019 09:27

Well worth watching!

Thank you

[macc1] 06/3/2019 09:05

Short video with CEO Manuel on todays results:

[jimmyloser] 06/3/2019 07:30

I don't see fireworks today either but they indicate the first of the pivotal news is expected within the next 21 days.
Several warnings on higher costs and hard Brexit but countered by solid sales outlook and new product progress

I thought the phrasing of the comment on PQ Birch was subtle

The PQ Birch product has... (been injected more than 26,000 times)... between 2005-2018 across Europe. Since the beginning of the TAV process in Germany in 2010, ...(two successful)... Phase II trials have been completed and the PQ Birch Phase III trial will read out ...(before the end of Q1 2019)... The delay has been caused by a longer than expected time needed by the Group's trial service providers to audit, review and consolidate data from the field trial.

Allergy Therapeutics remains blinded to the data package and... (management looks forward)... to receiving the data

We are where we are!

impo/dyor

[audigger] 06/3/2019 07:16

Solid performance. Still we await the key trial news but the current business alone should sustain a higher share price I remain optimistic they will develop a sustainable business in the US, but it's not without risk.

[jimmyloser] 05/3/2019 18:20

beccasan
Judging by the distinct lack of trading in AGY it appears that peeps all agree with you.

I never thought that I would see AGY at 14p and looking unloved again.

It will take something big tomorrow to have this on the move upwards but something small to see it slide!

God help us all if we need to fund raise soon.

impo/dyor

[beccasan] 26/2/2019 14:00

I find it hard to firmly believe in AGY as much as you do Jimmy. After all the discussions on this board over the last few months, I am just not that confident anymore. We shall see how the birch trials turn out, but at the moment the market seems to be weak and this company is looking particularly weak against competitors, as it looks like all AGY projects are quite outdated while other similar companies are moving at a faster pace. We shall see once they start putting out news with results, but I currently wouldn't get my hopes too high up, and given the present share price I assume big investors are just as sceptic.

[jimmyloser] 25/2/2019 15:58

So a matter of days to go before I expect much to be revealed. I have been buying in steadily and bought a large tranche earlier to-day.
But why?

Well I figure that our large seller has created an opportunity to buy. I believe the company and finally there is so much newsflow expected for instance

Regulatory

The Group continues to make good progress with the peanut allergy vaccine outsourced manufacturing scale up and the Acarovac Phase I trial for dust mite allergies. The first in-human trials for the Polyvac peanut product are expected to start in 2019, and data from the Acarovac Phase I trial is expected in H1 2019. As announced in December 2018, the top line results of the PQ Birch Phase III trial will be announced in Q1 2019. Meetings with the FDA and the German regulator, the Paul-Ehrlich-Institut (PEI), in relation to the PQ Grass trials are scheduled for Q1 2019.

Manuel Llobet, CEO at Allergy Therapeutics, stated: "This is another period of revenue growth and continued gain in market share for Allergy Therapeutics, in line with our mid and long-term strategy. The Group is also making good progress across its clinical pipeline, with a number of key developments anticipated for the first half of this year. We see momentum in the business and look forward to updating the market at our interim results."

DYOR but 14.12 to buy is unbelievable...impo that is.

[jimmyloser] 28/1/2019 11:03

If only we knew just how many more there are waiting to be dumped...appears to be steady buying all morning and then DUMP!

impo

[jimmyloser] 16/1/2019 16:16

Do we have a large order being filled?

[audigger] 16/1/2019 09:37

Steady on, 2 soft boiled eggs!

[jimmyloser] 16/1/2019 07:12

13.5p and this morning's RNS just do not make good bedfellows!
What a great start to the day. I may celebrate and have a soft boiled egg!
dyor/impo

[audigger] 16/1/2019 07:05

And indeed it is! A solid platform for the share price to have a think about some kind of recovery!

[jimmyloser] 08/1/2019 15:53

The big sleep will soon be over.
dyor!

[jimmyloser] 08/1/2019 15:27

HALLELUJAH!

blue!